• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Gilead Sciences Inc. (Nasdaq: GILD)

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. *

 

	Start	1987-06-22 established
	Group	Gilead Sciences (Group)
	Industry	biopharmaceutical
	Industry 2	virostatic agent
	Street	333 Lakeside Drive
	City	94404 Foster City, CA
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
	Currency	USD
	Annual sales	22,449,000,000 (revenues, total, consolidated (2019) 2019-12-31)
	Profit	5,364,000,000 (2019-12-31)
	Cash	25,840,000,000 (2019-12-31)
		* Document for �About Section�:
		Record changed: 2021-03-26

Advertisement

More documents for Gilead Sciences (Group)

• [1] Galapagos N.V.. (2/10/21). "Press Release: Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF". Foster City, CA & Mechelen....
• [2] Gilead Sciences, Inc.. (1/6/21). "Press Release: Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors". Santa Monica, CA, Oxford & San Jose, CA....
• [3] Galapagos N.V.. (12/15/20). "Press Release: Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca (filgotinib)". Foster City, CA & Mechelen....
• [4] Ori Biotech Ltd.. (12/15/20). "Press Release: Ori Biotech Adds to Its World-Class Team". London & Woodcliff Lake, NJ....
• [5] Gilead Sciences, Inc.. (12/10/20). "Press Release: Gilead Sciences to Acquire MYR GmbH". Foster City, CA & Bad Homburg....
• [6] Gilead Sciences, Inc.. (10/23/20). "Press Release: Gilead Sciences Completes Acquisition of Immunomedics, Inc.". Foster City, CA....
• [7] ProteoNic B.V.. (10/20/20). "Press Release: ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics". Leiden....
• [8] Gilead Sciences, Inc.. (9/13/20). "Press Release: Gilead Sciences to Acquire Immunomedics". Foster City, CA & Morris Plains, NJ....
• [9] Galapagos N.V.. (8/19/20). "Press Release: Galapagos Announces that Gilead Received a Complete Response Letter for Filgotinib for the Treatment of Moderately to Severely Active Rheumatoid Arthritis". Mechelen....
• [10] MYR GmbH. (8/4/20). "Press Release: MYR Pharmaceuticals Receives Conditional Marketing Authorization by the European Commission for Hepcludex". Bad Homburg....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.